Sie befinden sich hier
Targeting Angiopoietin-2 in diabetic complications
Supervisor (Mannheim): Yuxi Feng
Co-Supervisor (Groningen): Martina Schmidt
Graduate: Rachana Eshwaran
Hyperglycemia causes impairment of neuronal and vascular function in the retina and glomerular damage in the kidney, mediated by several biochemical pathways including the hexosamine pathway. The hexosamine pathway is heavily dependent on several metabolites from multiple metabolisms such as glucose, amino acid, fatty acid and nucleotide metabolism. This pathway is of vital importance in the regulation of angiopoietin-2 that is involved in the diabetic retinopathy and nephropathy. In this project, we aim to target angiopoietin-2 in diabetic complications, exploring the effect of a dietary supplement and its underlying mechanisms on the initiation of retinal vasoregression and glomerular damage in diabetes.
- *Shan et al Sci Rep. 2018; 12;8(1):10581.
- Tsai Mol Ther Nucleic Acids. 2018; 7;13:543-555.
- *Qiu, Acta diabetologica, 2016; 53(1), 81-89.
- *Feng Arterioscler Thromb Vasc Biol. 2014; 34(10):2292-300.
- *Hammes Diabetes 2004; 53(4), 1104-1110.
* Own publications
Cell culture, transfection, western blotting, qPCR, immunofluorescence, retinal morphometry, electroretinography, immunoprecipitation, FACS, mass spectrometry
- Martina Schmidt, Groningen
- Jens Kroll, Mannheim
- Hans-Peter Hammes, Mannheim